Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 May 19];8(6):s471. Available from: https://skin.dermsquared.com/skin/article/view/3130